Thirty-five units of botulinum toxin type A for treatment of axillary hyperhidrosis in female patients

Australas J Dermatol. 2011 May;52(2):123-6. doi: 10.1111/j.1440-0960.2010.00723.x. Epub 2011 Jan 12.

Abstract

We present a retrospective audit on efficacy and impact of 35 units of botulinum toxin type A per axilla on quality of life in female patients with axillary hyperhidrosis. This audit shows that 35 units of botulinum toxin type A is a reasonable starting dose and could significantly improve patients' quality of life and reduce the cost of treatment.

Publication types

  • Case Reports

MeSH terms

  • Axilla
  • Botulinum Toxins, Type A / administration & dosage*
  • Botulinum Toxins, Type A / economics
  • Female
  • Humans
  • Hyperhidrosis / drug therapy*
  • Hyperhidrosis / economics
  • Medical Audit
  • Neurotoxins / administration & dosage*
  • Neurotoxins / economics
  • Quality of Life
  • Retrospective Studies
  • Treatment Outcome

Substances

  • Neurotoxins
  • Botulinum Toxins, Type A